Respiratory Functions in Parkinson's Disease
Investigation of Respiratory Functions, Inspiratory Muscle Strength, Physical Fitness and Aerobic Capacity in Patients With Parkinson's Disease
1 other identifier
observational
100
1 country
1
Brief Summary
The aim is to examine respiratory functions, inspiratory muscle strength, respiratory function, physical fitness and aerobic capacity in Parkinson's disease patients. Individuals between the ages of 50-80 who have been diagnosed with Parkinson's disease by a neurologist and healthy individuals with similar demographic characteristics will be included in the study as a control group. In addition, patients will be divided into three groups as above and below 2.5 and healthy controls according to the Modified Hoehn and Yahr Scale. Demographic information of the individuals will be recorded and clinical evaluations will be made. The staging of Parkinson's patients will be done with the Modified Hoehn and Yahr Scale, and the severity of the disease will be done with the Unified Parkinson's Disease Rating Scale. The inspiratory muscle strength of the individuals will be evaluated with the PowerBreath K5, respiratory functions with the Pulmonary Function Test device, and physical fitness and aerobic capacity with the Senior Fitness Test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2025
CompletedFirst Posted
Study publicly available on registry
June 8, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedMarch 24, 2026
May 1, 2025
9 months
May 30, 2025
March 22, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Inspiratory Muscle Strength Measurement
In this study, the inspiratory muscle strength of the participants will be measured using the Power Breath device.
Baseline
Unified Parkinson's Disease Rating Scale
This scale will evaluate the severity and stage of the participants' Parkinson's disease.
Baseline
Evaluation of Respiratory Functions
Participants' respiratory functions will be evaluated using a standard respiratory function test device.
Baseline
Senior Fitness Test
The physical fitness levels of the participants will be evaluated using the Senior Fitness Test.
Baseline
Study Arms (3)
Early Stage Patients with Parkinson's Disease
According to the Modified Hoehn and Yahr Scale (MHÖ), patients with a score below 2.5
Advanced Stage Patients with Parkinson's Disease
According to the Modified Hoehn and Yahr Scale (MHÖ), patients with 2.5 and above
Control Group
Healthy individuals with similar demographic characteristics
Eligibility Criteria
Patients with Parkinson's disease who came to the neurology outpatient clinic for routine examination and who met the appropriate inclusion criteria and healthy individuals with similar demographic characteristics.
You may qualify if:
- Age 50 to 80
- Mini Mental State Examination score of 24 to 30
- Diagnosed with Parkinson's Disease by a neurologist
You may not qualify if:
- Sözlü iletişim kuramama
- Yürüme yardımcısı kullanıma
- Ciddi görme bozukluğu, ek nörolojik bozuklukları ve/veya konjestif kalp yetmezliği olan yaşlılar
- Egzersiz yapılması tavsiye edilmeyen yaşlı yetişkinler.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ankara Universitylead
- Hacettepe Universitycollaborator
- Atılım Universitycollaborator
Study Sites (1)
Atılım University
Ankara, Turkey (Türkiye)
Related Publications (2)
Shill H, Stacy M. Respiratory function in Parkinson's disease. Clin Neurosci. 1998;5(2):131-5.
PMID: 10785839RESULTMorris ME, Iansek R, Matyas TA, Summers JJ. Ability to modulate walking cadence remains intact in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1532-4. doi: 10.1136/jnnp.57.12.1532.
PMID: 7798986RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Süleyman Korkusuz, PhD
Atılım University
- STUDY CHAIR
Ayla Fil Balkan, Assoc Prof
Hacettepe University
- STUDY CHAIR
Gül Yalçın Çakmaklı, Assoc Prof
Hacettepe University
- STUDY CHAIR
Neslihan Durutürk, Prof.Dr
Baskent University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 30, 2025
First Posted
June 8, 2025
Study Start
July 1, 2025
Primary Completion
April 1, 2026
Study Completion
May 1, 2026
Last Updated
March 24, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share